Even when rats ate a diet high in phytic acid—which normally lowers mineral levels in the liver and bones—adding fructooligosaccharides restored those mineral levels to near-normal amounts.
Claim Context
In rats, the combination of fructooligosaccharides and phytic acid normalized liver and bone mineral levels that were reduced by phytic acid alone, indicating a protective effect of FOS on mineral homeostasis despite the presence of an antinutrient.
“However, the introduction of FOS into a PA diet counteracted these observed deleterious effects by stimulating bacterial hydrolysis of PA (+60% in rats adapted to FOS + PA compared to those fed the FF + PA diet) and by improving cecal absorption of minerals.”
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
Evidence from Studies
Supporting (1)
Community contributions welcome
When rats ate a substance (phytic acid) that normally steals minerals from their body, adding another substance (FOS) helped their gut bacteria break down the problem and let the minerals stay in their body instead. So, their bones and liver got back to normal mineral levels.
Contradicting (0)
Community contributions welcome
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether FOS consistently prevents or reverses mineral depletion in tissues caused by dietary phytic acid across animal models and human trials.
A systematic review and meta-analysis of all studies measuring liver, bone, and serum mineral concentrations in animals or humans consuming phytic acid with or without FOS, stratified by dose, duration, and baseline mineral status.
Whether daily FOS supplementation prevents bone and liver mineral loss in humans consuming high-phytate diets.
A double-blind RCT with 80 adults consuming a high-phytate diet (≥5 g/kg), randomized to 10 g/day FOS or placebo for 16 weeks, with primary outcomes of liver iron and zinc (via MRI spectroscopy) and tibia bone mineral density (via pQCT).
Whether habitual FOS intake is associated with higher liver and bone mineral stores in populations with high phytate intake.
A prospective cohort of 400 adults in high-phytate regions, measuring dietary FOS intake over 5 years and tracking liver iron (via serum ferritin) and bone mineral density (via DXA) annually, adjusting for phytate, vitamin D, and protein intake.
Whether individuals consuming more FOS have higher liver and bone mineral stores despite high phytate intake.
A cross-sectional survey of 300 adults measuring dietary FOS and phytate intake, serum ferritin, and bone mineral density via DXA, adjusting for age, sex, and total dietary fiber.
Whether an individual with low bone mineral density improves after starting FOS supplementation in a high-phytate diet.
A case series of 5 individuals with low bone mineral density and high phytate intake who begin 10 g/day FOS for 6 months, documenting changes in DXA scans and serum minerals.